Multiple U.S. IPOs are scheduled to price in mid-November 2026, including Rezera Inc. on November 12 and vVARDIS Holding AG plus Windward Bio Group AG on November 13, followed by Anthropic’s $61 billion offering on November 19. These reflect an active pipeline supported by recent S-1 and F-1 amendments, with 138 operating-company IPOs priced year-to-date amid normalized post-SpaceX conditions. Healthcare and AI-related issuers dominate recent filings and calendars, while broader equity-market sentiment, Treasury yields, and regulatory timelines influence deal timing. Additional smaller offerings and international listings further increase the likelihood of at least one completion before year-end.
This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange. If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No". This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET. The resolution source for this market is a consensus of credible reporting.